Authors: Chin, R Shaw, T Torresi, J Sozzi, V Trautwein, C Bock, T Manns, M Isom, H Furman, P Locarnini, S

Citation: R. Chin et al., In vitro susceptibilities of wild-type or drug-resistant hepatitis B virusto (-)-beta-D-2,6-diaminopurine dioxolane and 2 '-fluoro-5-methyl-beta-L-arabinofuranosyluracil, ANTIM AG CH, 45(9), 2001, pp. 2495-2501

Authors: Ying, C De Clercq, E Nicholson, W Furman, P Neyts, J

Citation: C. Ying et al., Inhibition of the replication of the DNA polymerase M550V mutation variantof human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir, J VIRAL HEP, 7(2), 2000, pp. 161-165

Authors: Szczech, GM Furman, P Painter, GR Barry, DW Borroto-Esoda, K Grizzle, TB Blum, MR Sommadossi, JP Endoh, R Niwa, T Yamamoto, M Moxham, C

Citation: Gm. Szczech et al., Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1, ANTIM AG CH, 44(1), 2000, pp. 123-130